Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients
Bauer, A.; Pachl, E.; Hellmuth, J. C.; Kneidinger, N.; Frankenberger, M.; Stubbe, H. C.; Ryffel, B.; Petrera, A.; Hauck, S. M.; Behr, J.; Kaiser, R.; Scherer, C.; Deng, L.; Teupser, D.; Ahmidi, N.; Muenchhoff, M.; Schubert, B.; Hilgendorff, A.
Show abstract
SARS-CoV-2 remains an acute threat to human health, endangering hospital capacities worldwide. Many studies have aimed at informing pathophysiologic understanding and identification of disease indicators for risk assessment, monitoring, and therapeutic guidance. While findings start to emerge in the general population, observations in high-risk patients with complex pre-existing conditions are limited. To this end, we biomedically characterized quantitative proteomics in a hospitalized cohort of COVID-19 patients with mild to severe symptoms suffering from different (co)-morbidities in comparison to both healthy individuals and patients with non-COVID related inflammation. Deep clinical phenotyping enabled the identification of individual disease trajectories in COVID-19 patients. By the use of this specific disease phase assignment, proteome analysis revealed a severity dependent general type-2 centered host response side-by-side with a disease specific antiviral immune reaction in early disease. The identification of phenomena such as neutrophil extracellular trap (NET) formation and a pro-coagulatory response together with the regulation of proteins related to SARS-CoV-2-specific symptoms by unbiased proteome screening both confirms results from targeted approaches and provides novel information for biomarker and therapy development. Graphical AbstractSars-CoV-2 remains a challenging threat to our health care system with many pathophysiological mechanisms not fully understood, especially in high-risk patients. Therefore, we characterized a cohort of hospitalized COVID-19 patients with multiple comorbidities by quantitative plasma proteomics and deep clinical phenotyping. The individual patients disease progression was determined and the subsequently assigned proteome profiles compared with a healthy and a chronically inflamed control cohort. The identified disease phase and severity specific protein profiles revealed an antiviral immune response together with coagulation activation indicating the formation of NETosis side-by-side with tissue remodeling related to the inflammatory signature. O_FIG O_LINKSMALLFIG WIDTH=197 HEIGHT=200 SRC="FIGDIR/small/22271106v1_ufig1.gif" ALT="Figure 1"> View larger version (50K): org.highwire.dtl.DTLVardef@1e791faorg.highwire.dtl.DTLVardef@20d3d6org.highwire.dtl.DTLVardef@1339e42org.highwire.dtl.DTLVardef@1db3710_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Plasma gradient of soluble urokinase-type plasminogen activator receptor is linked to pathogenic plasma proteome and immune transcriptome and stratifies outcomes in severe COVID-19 96%
- Persistent oxidative stress and inflammasome activation in CD14 high CD16 - monocytes from COVID-19 patients 95%
- T cell activation, highly armed cytotoxic cells and a sharp shift in monocytes CD300 receptors expression is characteristic of patients with severe COVID-19 95%
Similar papers in this journal
- Factor V is an immune inhibitor that is expressed at increased levels in leukocytes of patients with severe Covid-19 94%
- Distinct lipid profile, low-level inflammation and increased antioxidant defense as a signature in HIV-1 elite control status 94%
- Self-Collected Finger-Prick Blood for Gene Expression Profiling: Unveiling Early Immune Responses in Mild COVID-19 94%
Similar papers in this journal
- Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response 92%
- Metabolic rescue ameliorates mitochondrial encephalo-cardiomyopathy in murine and human iPSC models of Leigh syndrome 91%
- Effect of polymerized type I collagen in hyperinflammation of adult outpatients with symptomatic COVID-19: a double blind, randomised, placebo-controlled clinical trial 90%
Similar papers in this journal
- Is coagulation-protein consumption upon admission linked to COVID-19 severity and mortality? 94%
- Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms 93%
- IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.